Clinical Colorectal Cancer
Overview
Clinical Colorectal Cancer is a peer-reviewed medical journal that focuses on the diagnosis, treatment, and management of colorectal cancer. It publishes original research articles, clinical trials, and reviews, providing valuable insights into the latest advancements in this field. The journal aims to enhance the understanding of colorectal cancer and improve patient outcomes through evidence-based approaches and multidisciplinary collaboration.
Details
Details
Abbr.
Clin Colorectal Cancer
Publisher
Elsevier
Start
2001
End
Continuing
Frequency
Quarterly
p-ISSN
1533-0028
e-ISSN
1938-0674
Country
United States
Language
English
Specialties
Oncology
Gastroenterology
Gastroenterology
Metrics
Metrics
h-index / Ranks: 5814
63
SJR / Ranks: 2360
1336
CiteScore / Ranks: 3528
6.30
JIF / Ranks: 2884
3.4
Recent Articles
1.
Bhutiani N, Yousef M, Yousef A, Haque E, Chang G, Konishi T, et al.
Clin Colorectal Cancer
. 2025 Mar;
PMID: 40038019
Introduction: Extramural vascular invasion (EMVI) is associated with distant recurrence after treatment of locogionally advanced rectal adenocarcinomas (LARCs), but its use as a marker for response to neoadjuvant therapy is...
2.
Abrantes A, Caetano-Oliveira R, Oliveiros B, Cipriano M, Tralhao J
Clin Colorectal Cancer
. 2025 Feb;
PMID: 40021416
Background: More than 50% of patients diagnosed with colorectal cancer (CRC) will develop liver metastases (CRCLM), which is the main cause of death for more than 60% of these patients....
3.
Saarenheimo J, Willfor H, Wahid N, Jekunen A, Andersen H
Clin Colorectal Cancer
. 2025 Feb;
PMID: 40000255
Background: The application of fluoropyrimidine-based chemotherapy in colorectal cancer treatment is known to pose significant toxicity risks, which can be mitigated by tailoring treatment according to DPYD gene variants. This...
4.
Zwarthoed C, Jaraudias C, Evesque L, Baron D, Francois E, Chardin D, et al.
Clin Colorectal Cancer
. 2025 Feb;
PMID: 39988512
Background: The aim of this post hoc study was to assess the prognostic value of 18F-FDG PET/CT quantitative parameters recorded before and after treatment for anal canal neoplasm for the...
5.
Xu H, Zhuang J, Zhang C, Huang W, Chen B, Zheng B, et al.
Clin Colorectal Cancer
. 2025 Feb;
PMID: 39986979
Objective: To assess the impact of external iliac lymph node (N1b) metastasis on anal carcinoma (AC) staging and refine the Tumor-Node-Metastasis (TNM) system without modifying existing criteria. Methods: This retrospective...
6.
Lugnier C, Forster S, Sommerlatte S, Schoffer O, Christmann J, Kraeft A, et al.
Clin Colorectal Cancer
. 2025 Feb;
PMID: 39966037
Background: Colorectal cancer (CRC) remains a leading cause of death despite notable advancements through guideline-based management. We present data on changes of CRC care during the COVID-19 pandemic in Germany....
7.
Jacobsen C, Matos do Canto L, Kahns S, Hansen T, Andersen R
Clin Colorectal Cancer
. 2025 Feb;
PMID: 39956753
Liquid biopsies offer the possibility to evaluate cancer patients using noninvasive approaches. Circulating cell-free DNA (ccfDNA) is 1 of the most used and promising sources. Detecting tumor DNA among ccfDNA...
8.
Schietroma F, Bensi M, Calegari M, Pozzo C, Basso M, Valente G, et al.
Clin Colorectal Cancer
. 2025 Feb;
PMID: 39893137
Background: The management of colorectal cancer (CRC) is a complex process. Defining the disease burden, assessing the radiological response and identifying the right time for surgery or other locoregional treatments...
9.
Lucchetti J, Angotti L, Parisi A, Basso M, Polito M, Zoratto F, et al.
Clin Colorectal Cancer
. 2025 Jan;
PMID: 39856001
Background: Both aflibercept and bevacizumab-based regimens are available II-line treatment options for patients with metastatic colorectal cancer (mCRC). However, no head-to-head trials established the optimal anti-angiogenic strategy for this setting....
10.
Jiang W, Dou X, Zhang N, Yu J, Zhao L, Yue J
Clin Colorectal Cancer
. 2025 Jan;
PMID: 39826985
Background: Multidisciplinary team (MDT) meetings have been increasingly recognized for enhancing cancer treatment outcomes; however, their specific impact on stage II-III rectal cancer remains to be fully elucidated. Materials And...